Literature DB >> 3233790

Eosinophilic gastroenteritis: ultrastructural evidence for a selective release of eosinophil major basic protein.

G Torpier1, J F Colombel, C Mathieu-Chandelier, M Capron, J P Dessaint, A Cortot, J C Paris, A Capron.   

Abstract

Ultrastructural study of mucosal eosinophils in a case of eosinophilic gastroenteritis involving stomach, duodenum and ileum showed an altered structure in ulcerated duodenal areas. The electron core density of eosinophil granules was inverted or disappeared and tubulovesicular structures occurred. Using immunogold staining with specific antibodies, major basic protein was detected diffusely in the matrix of eosinophil granules and out of the granules in tight association with extragranular membrane formations. In contrast, eosinophil cationic protein and eosinophil peroxidase were normally distributed in the granule matrix. When compared with the eosinophils in macroscopically normal duodenal mucosa in the same patient, these changes support a role for major basic protein in tissue damage in eosinophilic gastroenteritis. The diffusion of one granule protein from the granules to the exterior of the cells favours the view of a selective release of eosinophil mediators.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3233790      PMCID: PMC1542005     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  The nuclear segmentation of eosinophils under normal and pathological conditions.

Authors:  S Sparrevohn; H R Wulff
Journal:  Acta Haematol       Date:  1967       Impact factor: 2.195

2.  Ultrastructural evidence for release of major basic protein-containing crystalline cores of eosinophil granules in vivo: cytotoxic potential in Crohn's disease.

Authors:  A M Dvorak
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

3.  Enhancement of structural preservation and immunocytochemical staining in low temperature embedded pancreatic tissue.

Authors:  J Roth; M Bendayan; E Carlemalm; W Villiger; M Garavito
Journal:  J Histochem Cytochem       Date:  1981-05       Impact factor: 2.479

4.  Mechanism of membrane damage mediated by eosinophil major basic protein.

Authors:  C Kroegel; U Costabel; H Matthys
Journal:  Lancet       Date:  1987-06-13       Impact factor: 79.321

5.  Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium.

Authors:  E Frigas; D A Loegering; G J Gleich
Journal:  Lab Invest       Date:  1980-01       Impact factor: 5.662

6.  Damage to Trichinella spiralis newborn larvae by eosinophil major basic protein.

Authors:  D L Wassom; G J Gleich
Journal:  Am J Trop Med Hyg       Date:  1979-09       Impact factor: 2.345

7.  Cytotoxic properties of the eosinophil major basic protein.

Authors:  G J Gleich; E Frigas; D A Loegering; D L Wassom; D Steinmuller
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

8.  Heterogeneity of human peripheral blood eosinophils: variability in cell density and cytotoxic ability in relation to the level and the origin of hypereosinophilia.

Authors:  L Prin; M Capron; A B Tonnel; O Bletry; A Capron
Journal:  Int Arch Allergy Appl Immunol       Date:  1983

9.  Role of IgE receptors in effector function of human eosinophils.

Authors:  M Capron; H L Spiegelberg; L Prin; H Bennich; A E Butterworth; R J Pierce; M A Ouaissi; A Capron
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

10.  Destruction of bloodstream forms of Trypanosoma cruzi by eosinophil granule major basic protein.

Authors:  F Kierszenbaum; S J Ackerman; G J Gleich
Journal:  Am J Trop Med Hyg       Date:  1981-07       Impact factor: 2.345

View more
  26 in total

1.  Helminthotoxic responses of intestinal eosinophils to Trichinella spiralis newborn larvae.

Authors:  T D Lee
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

2.  Activated eosinophils in coeliac disease.

Authors:  J F Colombel; A Janin; G Torpier
Journal:  Gut       Date:  1990-05       Impact factor: 23.059

3.  Lung Pathologies in a Chronic Inflammation Mouse Model Are Independent of Eosinophil Degranulation.

Authors:  Elizabeth A Jacobsen; Sergei I Ochkur; Alfred D Doyle; William E LeSuer; Wen Li; Cheryl A Protheroe; Dana Colbert; Katie R Zellner; HuaHao H Shen; Charles G Irvin; James J Lee; Nancy A Lee
Journal:  Am J Respir Crit Care Med       Date:  2017-05-15       Impact factor: 21.405

Review 4.  Food-Induced Acute Pancreatitis.

Authors:  Murli Manohar; Alok K Verma; Sathisha Upparahalli Venkateshaiah; Hemant Goyal; Anil Mishra
Journal:  Dig Dis Sci       Date:  2017-10-30       Impact factor: 3.199

5.  Enterolithiasis complicating eosinophilic enteritis: A case report and review of literature.

Authors:  Nairuthya Shivathirthan; Gaurav Maheshwari; Dinesh Kamath; Premashish Haldar
Journal:  World J Gastrointest Surg       Date:  2009-11-30

6.  Activated eosinophils and interleukin 5 expression in early recurrence of Crohn's disease.

Authors:  S Dubucquoi; A Janin; O Klein; P Desreumaux; P Quandalle; A Cortot; M Capron; J F Colombel
Journal:  Gut       Date:  1995-08       Impact factor: 23.059

7.  Segregation of eosinophil proteins in alveolar macrophage compartments in chronic eosinophilic pneumonia.

Authors:  A Janin; G Torpier; P Courtin; M Capron; L Prin; A B Tonnel; P Y Hatron; B Gosselin
Journal:  Thorax       Date:  1993-01       Impact factor: 9.139

8.  Activated eosinophils in adult coeliac disease: evidence for a local release of major basic protein.

Authors:  J F Colombel; G Torpier; A Janin; O Klein; A Cortot; M Capron
Journal:  Gut       Date:  1992-09       Impact factor: 23.059

Review 9.  Eosinophilic Gastroenteritis and Colitis: a Comprehensive Review.

Authors:  Vikas Uppal; Portia Kreiger; Erika Kutsch
Journal:  Clin Rev Allergy Immunol       Date:  2016-04       Impact factor: 8.667

10.  Vesicle-mediated secretion of human eosinophil granule-derived major basic protein.

Authors:  Rossana C N Melo; Lisa A Spencer; Sandra A C Perez; Josiane S Neves; Staci P Bafford; Ellen S Morgan; Ann M Dvorak; Peter F Weller
Journal:  Lab Invest       Date:  2009-04-27       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.